Literature DB >> 3149465

Insulin infusions in infants of birthweight less than 1250 g and with glucose intolerance.

P Heron1, D Bourchier.   

Abstract

Fifteen preterm babies (mean gestation: 26.7 weeks; mean birthweight 860 g) with significant glucose intolerance were treated with insulin infusions. During the insulin infusions there was a significant increase in both the mean energy intake (60.8 +/- 25.1 cal/kg per day to 79.9 +/- 24.5 cal/kg per day; P less than 0.001) and the mean amount of intravenous dextrose tolerated (7.0 +/- 2.7 mg/kg per min to 9.2 +/- 2.6 mg/kg per min; P less than 0.01). The infusions were initiated at a mean postnatal age of 5.3 days (range: 2-12 days) and were continued for 1.5-17.5 days. Of the 998 blood glucose estimations performed during the insulin infusions, 28 (2.8%) were less than 2 mmol/l and 216 (21.6%) greater than 8 mmol/l. We conclude that continuous insulin infusion is a safe and effective way of managing glucose intolerance in very low birthweight infants, provided adequate means for continuous monitoring of blood glucose are available.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3149465     DOI: 10.1111/j.1440-1754.1988.tb01390.x

Source DB:  PubMed          Journal:  Aust Paediatr J        ISSN: 0004-993X


  2 in total

Review 1.  Does continuous insulin infusion improve glycaemic control and nutrition in hyperglycaemic very low birth weight infants?

Authors:  V Kairamkonda
Journal:  Arch Dis Child       Date:  2006-01       Impact factor: 3.791

2.  A randomised controlled trial of early insulin therapy in very low birth weight infants, "NIRTURE" (neonatal insulin replacement therapy in Europe).

Authors:  Kathryn Beardsall; Sophie Vanhaesebrouck; Amanda L Ogilvy-Stuart; Jag S Ahluwalia; Christine Vanhole; Christopher Palmer; Paula Midgley; Mike Thompson; Luc Cornette; Mirjam Weissenbruch; Marta Thio; Francis de Zegher; David Dunger
Journal:  BMC Pediatr       Date:  2007-08-10       Impact factor: 2.125

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.